Back
Arcutis Biotherapeutics Stock Price Chart
Sponsored
ARQT
Sponsored
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
ARQT
Arcutis Biotherapeutics
Last Price:
10.16
Seasonality Move:
-19.37%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is moderately bearish and ARQT is experiencing slight buying pressure.
Arcutis Biotherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.36 | Sell |
20-day SMA: | 10.51 | Sell |
50-day SMA: | 9.91 | Buy |
200-day SMA: | 8.23 | Buy |
8-day EMA: | 10.33 | Sell |
20-day EMA: | 10.26 | Sell |
50-day EMA: | 9.92 | Buy |
200-day EMA: | 8.97 | Buy |
Arcutis Biotherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 49.72 | Sell |
Chaikin Money Flow: | 1424489 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.23 - 10.97) | Buy |
Bollinger Bands (100): | (8.36 - 10.32) | Buy |
Arcutis Biotherapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Arcutis Biotherapeutics Stock
Is Arcutis Biotherapeutics Stock a Buy?
- Arcutis Biotherapeutics share price is 10.15 while ARQT 8-day simple moving average is 10.36, which is a Sell signal.
- The stock price of ARQT is 10.15 while Arcutis Biotherapeutics 20-day SMA is 10.51, which makes it a Sell.
- Arcutis Biotherapeutics 50-day simple moving average is 9.91 while ARQT share price is 10.15, making it a Buy technically.
- ARQT stock price is 10.15 and Arcutis Biotherapeutics 200-day simple moving average is 8.23, creating a Buy signal.
ARQT Technical Analysis vs Fundamental Analysis
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy or a Sell?
-
Arcutis Biotherapeutics stock is rated a Sell
The current Arcutis Biotherapeutics [ARQT] share price is $10.15. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Arcutis Biotherapeutics Stock Info
Market Cap:
1.19B
Price in USD:
10.15
Share Volume:
3.6M
Arcutis Biotherapeutics 52-Week Range
52-Week High:
13.17
52-Week Low:
1.76
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Arcutis Biotherapeutics Share Price Forecast
-
What is the Arcutis Biotherapeutics stock price today?
The Arcutis Biotherapeutics stock price is 10.15 USD today. -
Will ARQT stock go up or go down?
Arcutis Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Arcutis Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcutis Biotherapeutics is overvalued.
Is Arcutis Biotherapeutics Stock a Buy?
- Arcutis Biotherapeutics share price is 10.15 while ARQT 8-day exponential moving average is 10.33, which is a Sell signal.
- The stock price of ARQT is 10.15 while Arcutis Biotherapeutics 20-day EMA is 10.26, which makes it a Sell.
- Arcutis Biotherapeutics 50-day exponential moving average is 9.92 while ARQT share price is 10.15, making it a Buy technically.
- ARQT stock price is 10.15 and Arcutis Biotherapeutics 200-day simple moving average is 8.97, creating a Buy signal.
Fundamental Analysis of Arcutis Biotherapeutics
Is Arcutis Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.
Technical Analysis of Arcutis Biotherapeutics
Should I short Arcutis Biotherapeutics stock?
- ARQT Moving Average Covergence Divergence (MACD) indicator is 0.16, suggesting Arcutis Biotherapeutics is a Buy
- Arcutis Biotherapeutics Relative Strength Index (RSI) is 49.72, which suggest Arcutis Biotherapeutics is oversold
- The Bollinger Bands (25) for Arcutis Biotherapeutics is (9.23 - 10.97), which suggest Arcutis Biotherapeutics is a Buy
- The Bollinger Bands (100) for Arcutis Biotherapeutics is (8.36 - 10.32), which suggest Arcutis Biotherapeutics is a Buy
* Arcutis Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.